BB Biotech

Bb Biotech as of March 31, 2014

Portfolio Holdings for Bb Biotech

Bb Biotech holds 24 positions in its portfolio as reported in the March 2014 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Celgene Corporation 15.7 $305M 2.2M 139.60
ISIS Pharmaceuticals 14.0 $272M 6.3M 43.21
Gilead Sciences (GILD) 12.8 $249M 3.5M 70.86
Incyte Corporation (INCY) 11.4 $221M 4.1M 53.52
Alexion Pharmaceuticals 5.7 $111M 727k 152.13
Vertex Pharmaceuticals Incorporated (VRTX) 5.1 $99M 1.4M 70.72
Medivation 4.8 $94M 1.5M 64.37
Synageva Biopharma 4.0 $78M 940k 82.97
Halozyme Therapeutics (HALO) 3.7 $72M 5.6M 12.70
Regeneron Pharmaceuticals (REGN) 3.5 $67M 223k 300.28
Pharmacyclics 3.3 $64M 637k 100.22
Endocyte 3.0 $59M 2.5M 23.81
Neurocrine Biosciences (NBIX) 2.5 $48M 3.0M 16.10
ImmunoGen (IMGN) 2.4 $47M 3.2M 14.93
Clovis Oncology 1.7 $34M 488k 69.27
Alnylam Pharmaceuticals (ALNY) 1.6 $32M 471k 67.14
Theravance 1.4 $28M 888k 30.94
Tesaro 0.9 $18M 605k 29.48
Infinity Pharmaceuticals (INFIQ) 0.8 $16M 1.3M 11.89
Puma Biotechnology (PBYI) 0.6 $12M 118k 104.14
Idenix Pharmaceuticals 0.4 $7.5M 1.3M 6.03
Achillion Pharmaceuticals 0.3 $5.9M 1.8M 3.29
Ariad Pharmaceuticals 0.1 $1.4M 172k 8.06
Cubist Pharmaceutic-cvr 0.0 $570k 876k 0.65